EP Patent

EP1575591A4 — Heterocycles and uses thereof

Assigned to Ariad Pharmaceuticals Inc · Expires 2007-09-12 · 19y expired

What this patent protects

Compounds of the following formula are disclosed: wherein RB is a substituted or unsubstituted aryl or heteroaryl moiety; at least one of RU and RL is a phosphorus-containing moiety, J, and the other of RU and RL is independently chosen from H; halogen; -CN; -N02; -J; -SO2R; -S02…

USPTO Abstract

Compounds of the following formula are disclosed: wherein RB is a substituted or unsubstituted aryl or heteroaryl moiety; at least one of RU and RL is a phosphorus-containing moiety, J, and the other of RU and RL is independently chosen from H; halogen; -CN; -N02; -J; -SO2R; -S02NRR'; or -ZRJ, wherein each occurrence of Z is independently -0-, -S- or -NR- and each occurrence of RJ is independently -R, -COR, -COOR or -CONRR.

Drugs covered by this patent

Patent Metadata

Patent number
EP1575591A4
Jurisdiction
EP
Classification
—
Expires
2007-09-12
Drug substance claim
No
Drug product claim
No
Assignee
Ariad Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.